Transforming growth factor-beta and its implication in the malignancy of gliomas.
about
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survivalCannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cellsTGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune ResponseGalunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes.Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta.HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.The effect of yacon (Samallanthus sonchifolius) ethanol extract on cell proliferation and migration of C6 glioma cells stimulated with fetal bovine serumUse of HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells as a Potential Therapeutic for Progressive HER2-Positive Glioblastoma.CD133 positive U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment.Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.Endothelin-1 (ET-1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors and de novo protein synthesis.Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathwayMicroglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors
P2860
Q28078539-16DAA0DB-9589-4FC8-B300-C6BCA4BE30AEQ35798846-BCA6B0F8-C65E-40E2-8EEE-A87B8D92A714Q36021048-16E95DEF-9DF7-42DC-8410-1C138B5219DEQ36378043-7301D1DA-3CD3-4F28-9487-D21E615D6269Q36686638-C64F6F37-2208-4DF4-B49F-263AC37EBB55Q37362574-F3982108-BC41-4B69-AECE-5ED42EA0D85CQ37503365-8DB1E037-0D49-481B-9911-04E25F1A1463Q38843924-6D0846F4-FB74-4A80-82A9-3BFFB690066CQ40234446-92ADD74E-7B69-4736-AB04-412955D08B87Q42043418-65020C13-7543-45E8-A792-6DFAA9BB766DQ45325460-93C9E09F-DEF2-40E3-8428-C73E82DB371EQ48096598-ABA394BC-51E9-46CE-A764-0D2929D772BEQ50586476-FDD6F60B-24EF-4EA3-8C83-A3EC19BDBAF8Q51034572-8BAAEA7D-49A9-4DF7-9D90-54FC9938CC9CQ52593655-AB4D41A9-13DF-46FD-9039-618CC57C8221Q57116103-535BEE22-0267-45E7-9E7F-E5CB1D987FC2Q58801546-8B8BF450-28F3-4B0A-AB1A-889FBFF98186
P2860
Transforming growth factor-beta and its implication in the malignancy of gliomas.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Transforming growth factor-beta and its implication in the malignancy of gliomas.
@en
type
label
Transforming growth factor-beta and its implication in the malignancy of gliomas.
@en
prefLabel
Transforming growth factor-beta and its implication in the malignancy of gliomas.
@en
P2093
P2860
P1433
P1476
Transforming growth factor-beta and its implication in the malignancy of gliomas.
@en
P2093
David Fortin
Laurent-Olivier Roy
Marie-Belle Poirier
P2860
P2888
P356
10.1007/S11523-014-0308-Y
P577
2014-03-05T00:00:00Z
P6179
1033056945